Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för ethylisopropylamiloride. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

9 träffar

Bibliografisk träff 2015-08-01

Acidosis and 5-(N-ethyl-N-isopropyl)amiloride (EIPA) Attenuate Zinc/Kainate Toxicity in Cultured Cerebellar Granule Neurons.

Stelmashook EV, Novikova SV, Amelkina GA, Ivashkin EG, Genrikhs EE, Khaspekov LG, Isaev NK.

Biochemistry (Mosc) · research support, non-u.s. gov't; journal article · DOI 10.1134/s000629791508012x

Bibliografisk träff 2015-05-16

Experimental Study of the Effects of EIPA, Losartan, and BQ-123 on Electrophysiological Changes Induced by Myocardial Stretch.

Chorro FJ, Canto ID, Brines L, Such-Miquel L, Calvo C, Soler C, Zarzoso M, Trapero I, Tormos Á, Such L.

Rev Esp Cardiol (Engl Ed) · research support, non-u.s. gov't; journal article · DOI 10.1016/j.rec.2014.12.023

Bibliografisk träff 2013-07-17

SLC4A11 is an EIPA-sensitive Na(+) permeable pHi regulator.

Ogando DG, Jalimarada SS, Zhang W, Vithana EN, Bonanno JA.

Am J Physiol Cell Physiol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1152/ajpcell.00056.2013

Bibliografisk träff 2012-10-19

An inhibitor of Na(+)/H(+) exchanger (NHE), ethyl-isopropyl amiloride (EIPA), diminishes proliferation of MKN28 human gastric cancer cells by decreasing the cytosolic Cl(-) concentration via DIDS-sensitive pathways.

Hosogi S, Miyazaki H, Nakajima K, Ashihara E, Niisato N, Kusuzaki K, Marunaka Y.

Cell Physiol Biochem · research support, non-u.s. gov't; journal article · DOI 10.1159/000343315

Bibliografisk träff 2010-03-24

Inhibition of Na(+)/H(+) exchanger 1 by 5-(N-ethyl-N-isopropyl) amiloride reduces hypoxia-induced hepatocellular carcinoma invasion and motility.

Yang X, Wang D, Dong W, Song Z, Dou K.

Cancer Lett · research support, non-u.s. gov't; journal article · DOI 10.1016/j.canlet.2010.03.001

Bibliografisk träff 2005-07-01

Dual modes of 5-(N-ethyl-N-isopropyl)amiloride modulation of apical dipeptide uptake in the human small intestinal epithelial cell line Caco-2.

Kennedy DJ, Raldua D, Thwaites DT.

Cell Mol Life Sci · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1007/s00018-005-5078-3

Bibliografisk träff 2003-07-01

Ethyl isopropyl amiloride inhibits smooth muscle cell proliferation and migration by inducing apoptosis and antagonizing urokinase plasminogen activator activity.

Chen YX, O'Brien ER.

Can J Physiol Pharmacol · research support, non-u.s. gov't; journal article · DOI 10.1139/y03-066

Bibliografisk träff 1999-08-01

5-(N-Ethyl-N-isopropyl)-amiloride, an Na(+)-H(+) exchange inhibitor, protects gerbil hippocampal neurons from ischemic injury.

Phillis JW, Estevez AY, Guyot LL, O'Regan MH.

Brain Res · journal article · DOI 10.1016/s0006-8993(99)01705-9

Bibliografisk träff 1997-10-01

The mechanism of protection from 5 (N-ethyl-N-isopropyl)amiloride differs from that of ischemic preconditioning in rabbit heart.

Sato H, Miki T, Vallabhapurapu RP, Wang P, Liu GS, Cohen MV, Downey JM.

Basic Res Cardiol · comparative study; research support, u.s. gov't, p.h.s.; journal article · DOI 10.1007/bf00788946